Alpha Tau Medical (DRTS) Projected to Post Earnings on Monday

Alpha Tau Medical (NASDAQ:DRTS) will likely be releasing its Q1 2025 earnings data before the market opens on Monday, May 19th. Analysts expect Alpha Tau Medical to post earnings of ($0.14) per share for the quarter.

Alpha Tau Medical (NASDAQ:DRTS) last posted its earnings results on Wednesday, March 12th. The company reported ($0.13) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.13). On average, analysts expect Alpha Tau Medical to post $0 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Alpha Tau Medical Stock Down 5.7%

DRTS stock opened at $2.79 on Friday. Alpha Tau Medical has a twelve month low of $1.75 and a twelve month high of $4.39. The stock’s 50 day moving average is $2.63 and its 200-day moving average is $2.89. The firm has a market capitalization of $196.36 million, a PE ratio of -6.49 and a beta of 0.92.

Wall Street Analyst Weigh In

Separately, HC Wainwright reiterated a “buy” rating and set a $9.00 price target on shares of Alpha Tau Medical in a report on Tuesday, April 29th.

Alpha Tau Medical Company Profile

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.